Literature DB >> 17509102

Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study.

A Lembo1, M Zaman, M Jones, N J Talley.   

Abstract

BACKGROUND: A genetic contribution has been proposed for irritable bowel syndrome (IBS) and gastro-oesophageal reflux disease (GERD), but is controversial. No twin data exist for dyspepsia. AIM: To determine the relative contribution of genetic factors in GERD, dyspepsia (upper abdominal pain) and IBS.
METHODS: A total of 986 twin pairs (from initial mail-out response 51%). Both members completed validated symptom and psychological questionnaires; 481 monozygotic pairs [mean (s.d.) age 53 +/- 5.8 years] and 505 dizygotic pairs (mean age 54 +/- 5.6 years).
RESULTS: Prevalence of IBS, dyspepsia and GERD was 12%, 10% and 20%, respectively. Polychoric correlation for monozygotic twins for IBS (0.47) and GERD (0.44) were both substantially larger than those for dizygotic twins (0.17 and -0.37, respectively). Polychoric correlation was slightly lower in monozygotic than dizygotic twins for dyspepsia. Genetic modelling confirmed the independent additive genetic effects in GERD and IBS but not dyspepsia. Estimates of genetic variance were 22% for IBS, 13% for GERD and 0% for dyspepsia, but adjusting for anxiety and depression removed the statistical significance for IBS and GERD.
CONCLUSIONS: There is a genetic contribution to GERD and IBS but not dyspepsia; this may be mediated by the hereditability of anxiety and depression.

Entities:  

Mesh:

Year:  2007        PMID: 17509102     DOI: 10.1111/j.1365-2036.2007.03326.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  48 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

2.  Familial aggregation of irritable bowel syndrome: a family case-control study.

Authors:  Yuri A Saito; Gloria M Petersen; Joseph J Larson; Elizabeth J Atkinson; Brooke L Fridley; Mariza de Andrade; G Richard Locke; Janice M Zimmerman; Ann E Almazar-Elder; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2010-03-16       Impact factor: 10.864

3.  Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders.

Authors:  Gareth J Sanger; Lin Chang; Chas Bountra; Lesley A Houghton
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

4.  Increased Gut Permeability in First-degree Relatives of Children with Irritable Bowel Syndrome or Functional Abdominal Pain.

Authors:  Mark McOmber; Danny Rafati; Kevin Cain; Sridevi Devaraj; Erica M Weidler; Margaret Heitkemper; Robert J Shulman
Journal:  Clin Gastroenterol Hepatol       Date:  2019-05-14       Impact factor: 11.382

5.  Dissecting GI phenotype-genotype relationships in GERD and dyspepsia: an SNP here and an SNP there!

Authors:  Janusz A Jankowski; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2009-01-20       Impact factor: 10.864

6.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 7.  Managing Chronic Pain in Special Populations with Emphasis on Pediatric, Geriatric, and Drug Abuser Populations.

Authors:  Kyle M Baumbauer; Erin E Young; Angela R Starkweather; Jessica W Guite; Beth S Russell; Renee C B Manworren
Journal:  Med Clin North Am       Date:  2016-01       Impact factor: 5.456

8.  Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: results from the EPIFUND study.

Authors:  Kate L Holliday; Gary J Macfarlane; Barbara I Nicholl; Francis Creed; Wendy Thomson; John McBeth
Journal:  J Psychosom Res       Date:  2010-05       Impact factor: 3.006

9.  Current insights in to the pathophysiology of Irritable Bowel Syndrome.

Authors:  Theodoros Karantanos; Theofano Markoutsaki; Maria Gazouli; Nicholas P Anagnou; Dimitrios G Karamanolis
Journal:  Gut Pathog       Date:  2010-05-13       Impact factor: 4.181

10.  Collagen type III alpha I is a gastro-oesophageal reflux disease susceptibility gene and a male risk factor for hiatus hernia.

Authors:  B Asling; J Jirholt; P Hammond; M Knutsson; A Walentinsson; G Davidson; L Agreus; A Lehmann; M Lagerström-Fermer
Journal:  Gut       Date:  2009-04-26       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.